UW Vaccine & Treatment Evaluation Unit

Research Opportunities


July 12, 2021

Updated 7/12/2021: “Mix ‘n Match” Booster COVID-19 Vaccine Clinical Trial

The University of Washington is seeking volunteers for a Phase 1/2 COVID-19 vaccine booster trial to test the safety and effectiveness of additional doses of EUA vaccines in people who have received an EUA vaccine series.


April 21, 2021

Gritstone COVID-19 Vaccine Clinical Trial

Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults This is a multicenter, US-only, phase 1, open-label, dose and age escalation, parallel design (heterologous and homologous prime-boost) study to examine safety, tolerability, and immunogenicity of investigational Chimpanzee Adenovirus serotype 68 (ChAd) and self-amplifying mRNA (SAM) vectors expressing either Severe Acute Respiratory…


December 28, 2020

Novavax COVID-19 Vaccine Trial

We are currently enrolling members of the public in a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or…